Home » Investment Services & Trading, Picture Gallery » CSE: 2017-0301 – Reinstatement – Abattis Bioceuticals Corp. (ATT)

CSE: 2017-0301 – Reinstatement – Abattis Bioceuticals Corp. (ATT)






TORONTO, ONTARIO — (Marketwired) — 03/03/17 — Effective immediately the shares of Abattis Bioceuticals Corp. will be reinstated for trading.

The Company has rectified the default situation that gave rise to the suspension.

Effective Date: March 3, 2017

Symbol: ATT

Contacts:
Canadian Securities Exchange (CSE)
Listings
(416) 367-7340

Short URL: https://www.88finance.com/?p=527993





Posted by on Mar 3 2017. Filed under Investment Services & Trading, Picture Gallery. You can follow any responses to this entry through the RSS 2.0. You can leave a response or trackback to this entry

Leave a Reply

Analytics

© 2020 88Finance. All Rights Reserved. Log in - Copyright by LayerMedia


Blogverzeichnis - Blog Verzeichnis bloggerei.de Blog Top Liste - by TopBlogs.de